Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,428 | 140,418 | 49,826 | 22,061 | 69,482 |
| Marketable Securities | 282,046 | 259,715 | 193,482 | 120,474 | 139,518 |
| Receivables | 37,591 | 5,048 | 3,583 | 5,196 | 2,828 |
| TOTAL | $405,473 | $410,521 | $248,397 | $149,580 | $212,582 |
| Non-Current Assets | |||||
| PPE Net | 29,926 | 78,723 | 31,066 | 6,557 | 2,916 |
| Investments And Advances | 21,832 | 0 | 1,012 | 0 | 0 |
| Intangibles | 92,429 | 94,287 | 1,585 | 1,585 | 1,585 |
| Other Non-Current Assets | 87,856 | 6,864 | 4,681 | 169 | 152 |
| TOTAL | $232,043 | $179,874 | $38,344 | $8,311 | $4,653 |
| Total Assets | $637,516 | $590,395 | $286,741 | $157,891 | $217,235 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,671 | 21,457 | 11,035 | 6,261 | 8,229 |
| Accrued Expenses | 13,605 | 9,490 | 5,479 | 2,885 | 2,748 |
| TOTAL | $69,872 | $78,511 | $44,859 | $13,291 | $20,097 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 38,711 | 47,564 | 28,345 | 4,145 | 9,120 |
| Other Non-Current Liabilities | 47,136 | 2,515 | 0 | 0 | 0 |
| TOTAL | $134,905 | $144,627 | $53,982 | $8,405 | $4,699 |
| Total Liabilities | $204,777 | $223,138 | $98,841 | $21,696 | $24,796 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,023 | 102,273 | 86,339 | 70,875 | 70,369 |
| Common Shares | 1,160 | 1,022 | 856 | 709 | 703 |
| Retained earnings | -656,985 | -562,696 | -495,479 | -440,911 | -369,253 |
| Other shareholders' equity | -2,264 | -701 | -286 | 20 | 0 |
| TOTAL | $432,739 | $367,257 | $187,900 | $136,195 | $192,439 |
| Total Liabilities And Equity | $637,516 | $590,395 | $286,741 | $157,891 | $217,235 |